Citations (57)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Sergei Nekhai & Namita Kumari. (2022) HIV-1 infection in sickle cell disease and sickle cell trait: role of iron and innate response. Expert Review of Hematology 15:3, pages 253-263.
Read now
Read now
Rajesh H. Vekariya, Kinjal D. Patel, Dhanji P. Rajani, Smita D. Rajani & Hitesh D. Patel. (2017) A one pot, three component synthesis of coumarin hybrid thiosemicarbazone derivatives and their antimicrobial evolution. Journal of the Association of Arab Universities for Basic and Applied Sciences 23:1, pages 10-19.
Read now
Read now
Jimin Shao, Xiyong Liu, Lijun Zhu & Yun Yen. (2013) Targeting ribonucleotide reductase for cancer therapy. Expert Opinion on Therapeutic Targets 17:12, pages 1423-1437.
Read now
Read now
Apostolia-Maria Tsimberidou & Francis J. Giles. (2002) Essential Thrombocythemia (ET): Moving from Palliation to Cure. Hematology 7:6, pages 315-323.
Read now
Read now
Articles from other publishers (53)
Erum Razvi, Benjamin R. DiFrancesco, Gregory A. Wasney, Zachary A. Morrison, John Tam, Anick Auger, Perrin Baker, Noor Alnabelseya, Jacquelyn D. Rich, Piyanka Sivarajah, Gregory B. Whitfield, Joe J. Harrison, Roman A. Melnyk, Mark Nitz & P. Lynne Howell. (2023) Small Molecule Inhibition of an Exopolysaccharide Modification Enzyme is a Viable Strategy To Block Pseudomonas aeruginosa Pel Biofilm Formation. Microbiology Spectrum 11:3.
Crossref
Crossref
Akhalesh Kumar, Rakhi Mishra, Avijit Mazumder, Rupa Mazumder & Shruti Varshney. (2023) Exploring Synthesis and Chemotherapeutic Potential of Thiosemicarbazide Analogs. Anti-Cancer Agents in Medicinal Chemistry 23:1, pages 60-75.
Crossref
Crossref
George J. Kontoghiorghes. (2022) New Iron Metabolic Pathways and Chelation Targeting Strategies Affecting the Treatment of All Types and Stages of Cancer. International Journal of Molecular Sciences 23:22, pages 13990.
Crossref
Crossref
Ying-Xue Liu, Lin-Bao Zhu, Zhe-Xiao Guo, Han-Dan Zhu, Zhi-Hao Huang, Hui-Hua Cao, Hai-Zhong Yu, Shi-Huo Liu & Jia-Ping Xu. (2022) Bombyx mori ferritin heavy-chain homolog facilitates BmNPV proliferation by inhibiting reactive oxygen species–mediated apoptosis. International Journal of Biological Macromolecules 217, pages 842-852.
Crossref
Crossref
Marta Ribeiro, Cátia A. Sousa & Manuel Simões. (2022) Harnessing microbial iron chelators to develop innovative therapeutic agents. Journal of Advanced Research 39, pages 89-101.
Crossref
Crossref
Michael Tsui, Weixian Min, Stephanie Ng, Kerry Dobbs, Luigi D. Notarangelo, Yigal Dror & Eyal Grunebaum. (2021) The Use of Induced Pluripotent Stem Cells to Study the Effects of Adenosine Deaminase Deficiency on Human Neutrophil Development. Frontiers in Immunology 12.
Crossref
Crossref
Fei Hao, Xueyun Shang, Zhenwei Liu, He Zhang, Jin-Hong Lin & Ji-Chang Xiao. (2021) Rh-catalyzed tunable defluorinative borylation. Chemical Communications 57:58, pages 7124-7127.
Crossref
Crossref
Akhalesh Kumar, Rakhi Mishra, Avijit Mazumder, Rupa Mazumder & Arun Kumar. (2021) An Updated Review on Synthesis and Biological Activities of Thiosemicarbazide Analogs. Asian Journal of Chemistry 33:9, pages 1957-1975.
Crossref
Crossref
Enrico Baruffini, Roberta Ruotolo, Franco Bisceglie, Serena Montalbano, Simone Ottonello, Giorgio Pelosi, Annamaria Buschini & Tiziana Lodi. (2020) Mechanistic insights on the mode of action of an antiproliferative thiosemicarbazone-nickel complex revealed by an integrated chemogenomic profiling study. Scientific Reports 10:1.
Crossref
Crossref
Petra HeffeterVeronika F.S. PapeÉva A. EnyedyBernhard K. KepplerGergely SzakacsChristian R. Kowol. (2019) Anticancer Thiosemicarbazones: Chemical Properties, Interaction with Iron Metabolism, and Resistance Development. Antioxidants & Redox Signaling 30:8, pages 1062-1082.
Crossref
Crossref
Rayan S. Moussa, Kyung Chan Park, Zaklina Kovacevic & Des R. Richardson. (2019) Ironing out the role of the cyclin-dependent kinase inhibitor, p21 in cancer: Novel iron chelating agents to target p21 expression and activity. Free Radical Biology and Medicine 133, pages 276-294.
Crossref
Crossref
A. G. Mal’kina, V. V. Nosyreva, A. V. Afonin, A. I. Albanov, Q. A. Apartsin, E. G. Grigor’ev & B. A. Trofimov. (2017) Regio- and stereoselective N 2-functionalization with propanamide fragment of aromatic and heteroaromatic aldehydes thiosemicarbazones. Russian Journal of Organic Chemistry 53:8, pages 1226-1232.
Crossref
Crossref
Ghodrat Mahmoudi, Alfonso Castiñeiras, Piotr Garczarek, Antonio Bauzá, Arnold L. Rheingold, Vasyl Kinzhybalo & Antonio Frontera. (2016)
Synthesis, X-ray characterization, DFT calculations and Hirshfeld surface analysis of thiosemicarbazone complexes of M
n+
ions (n = 2, 3; M = Ni, Cd, Mn, Co and Cu)
. CrystEngComm 18:6, pages 1009-1023.
Crossref
Crossref
Goldie Y.L. Lui, Zaklina Kovacevic, Vera Richardson, Angelica M. Merlot, Danuta S. Kalinowski & Des R. Richardson. (2015) Targeting cancer by binding iron: Dissecting cellular signaling pathways. Oncotarget 6:22, pages 18748-18779.
Crossref
Crossref
Satya P. Gupta. (2015) QSAR Studies on Hydroxamic Acids: A Fascinating Family of Chemicals with a Wide Spectrum of Activities. Chemical Reviews 115:13, pages 6427-6490.
Crossref
Crossref
Carmen Avendaño & J. Carlos Menéndez. 2015. Medicinal Chemistry of Anticancer Drugs. Medicinal Chemistry of Anticancer Drugs
23
79
.
Namita Kumari, Sergey Iordanskiy, Dmytro Kovalskyy, Denitra Breuer, Xiaomei Niu, Xionghao Lin, Min Xu, Konstantin Gavrilenko, Fatah Kashanchi, Subhash Dhawan & Sergei Nekhai. (2014) Phenyl-1-Pyridin-2yl-Ethanone-Based Iron Chelators Increase IκB-α Expression, Modulate CDK2 and CDK9 Activities, and Inhibit HIV-1 Transcription. Antimicrobial Agents and Chemotherapy 58:11, pages 6558-6571.
Crossref
Crossref
S Senese, Y C Lo, D Huang, T A Zangle, A A Gholkar, L Robert, B Homet, A Ribas, M K Summers, M A Teitell, R Damoiseaux & J Z Torres. (2014) Chemical dissection of the cell cycle: probes for cell biology and anti-cancer drug development. Cell Death & Disease 5:10, pages e1462-e1462.
Crossref
Crossref
Darius J.R. Lane, Thomas M. Mills, Nurul H. Shafie, Angelica M. Merlot, Rayan Saleh Moussa, Danuta S. Kalinowski, Zaklina Kovacevic & Des R. Richardson. (2014) Expanding horizons in iron chelation and the treatment of cancer: Role of iron in the regulation of ER stress and the epithelial–mesenchymal transition. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1845:2, pages 166-181.
Crossref
Crossref
Sergei NekhaiNamita Kumari & Subhash Dhawan. (2013) Role of cellular iron and oxygen in the regulation of HIV-1 infection. Future Virology 8:3, pages 301-311.
Crossref
Crossref
Arghya Basu, Durairaj Thiyagarajan, Chirantan Kar, Aiyagari Ramesh & Gopal Das. (2013) Synthesis, crystal structure and bio-macromolecular interaction studies of pyridine-based thiosemicarbazone and its Ni(ii) and Cu(ii) complexes. RSC Advances 3:33, pages 14088.
Crossref
Crossref
N. S. Hari Narayana Moorthy, Nuno M. F. S. A. Cerqueira, Maria J. Ramos & Pedro A. Fernandes. (2011) QSAR and pharmacophore analysis of thiosemicarbazone derivatives as ribonucleotide reductase inhibitors. Medicinal Chemistry Research 21:6, pages 739-746.
Crossref
Crossref
Josephine AimiuwuHongyan WangPing ChenZhiliang XieJiang WangShujun Liu, Rebecca Klisovic, Alice Mims, William Blum, Guido Marcucci & Kenneth K. Chan. (2012) RNA-dependent inhibition of ribonucleotide reductase is a major pathway for 5-azacytidine activity in acute myeloid leukemia. Blood 119:22, pages 5229-5238.
Crossref
Crossref
N. S. Hari Narayana Moorthy, Nuno S. Cerqueira, Maria J. Ramos & Pedro A. Fernandes. (2010) QSAR analysis of 2-benzoxazolyl hydrazone derivatives for anticancer activity and its possible target prediction. Medicinal Chemistry Research 21:2, pages 133-144.
Crossref
Crossref
Sergei Nekhai & Victor R. Gordeuk. 2012. Iron Physiology and Pathophysiology in Humans. Iron Physiology and Pathophysiology in Humans
477
495
.
Arijit Basu, Barij N. Sinha, Philipp Saiko, Geraldine Graser & Thomas Szekeres. (2011) N-Hydroxy-N′-aminoguanidines as anti-cancer lead molecule: QSAR, synthesis and biological evaluation. Bioorganic & Medicinal Chemistry Letters 21:11, pages 3324-3328.
Crossref
Crossref
Zufan Debebe, Tatyana Ammosova, Denitra Breuer, David B. Lovejoy, Danuta S. Kalinowski, Pradeep K. Karla, Krishna Kumar, Marina Jerebtsova, Patricio Ray, Fatah Kashanchi, Victor R. Gordeuk, Des R. Richardson & Sergei Nekhai. (2011) Iron Chelators of the Di-2-pyridylketone Thiosemicarbazone and 2-Benzoylpyridine Thiosemicarbazone Series Inhibit HIV-1 Transcription: Identification of Novel Cellular Targets—Iron, Cyclin-Dependent Kinase (CDK) 2, and CDK9. Molecular Pharmacology 79:1, pages 185-196.
Crossref
Crossref
Philipp Saiko, Geraldine Graser, Benedikt Giessrigl, Andreas Lackner, Michael Grusch, Georg Krupitza, Arijit Basu, Barij Nayan Sinha, Venkatesan Jayaprakash, Walter Jaeger, Monika Fritzer-Szekeres & Thomas Szekeres. (2011) A novel N-hydroxy-N′-aminoguanidine derivative inhibits ribonucleotide reductase activity: Effects in human HL-60 promyelocytic leukemia cells and synergism with arabinofuranosylcytosine (Ara-C). Biochemical Pharmacology 81:1, pages 50-59.
Crossref
Crossref
Nha T.P. Vo, Sibylle Madlener, Zsuzsanna Bago-Horvath, Irene Herbacek, Nicole Stark, Manuela Gridling, Paul Probst, Benedikt Giessrigl, Sabine Bauer, Caroline Vonach, Philipp Saiko, Michael Grusch, Thomas Szekeres, Monika Fritzer-Szekeres, Walter Jäger, Georg Krupitza & Afschin Soleiman. (2010) Pro- and anticarcinogenic mechanisms of piceatannol are activated dose dependently in MCF-7 breast cancer cells. Carcinogenesis 31:12, pages 2074-2081.
Crossref
Crossref
Pedro Besada, Tamara Costas, Marta Teijeira & Carmen Terán. (2010) Synthesis and cytostatic activity of purine nucleosides derivatives of allofuranose. European Journal of Medicinal Chemistry 45:12, pages 6114-6119.
Crossref
Crossref
Jin-Lan Yu, Qin-Pei Wu, Qing-Shan Zhang, Xiao-Dong Xi, Ning-Ning Liu, Yun-Zheng Li, Yan-Hong Liu & Hong-Quan Yin. (2010) Synthesis and antitumor activity of novel 2′,3′-diethanethio-2′,3′,5′-trideoxy-5′-triazolonucleoside analogues. European Journal of Medicinal Chemistry 45:7, pages 3219-3222.
Crossref
Crossref
Jin-Lan Yu, Qin-Pei Wu, Qing-Shan Zhang, Yan-Hong Liu, Yun-Zheng Li & Zi-Ming Zhou. (2010) Synthesis and antitumor activity of novel 2′,3′-dideoxy-2′,3′-diethanethionucleosides bearing 1,2,3-triazole residues. Bioorganic & Medicinal Chemistry Letters 20:1, pages 240-243.
Crossref
Crossref
Korakod Chimploy, G. Dario Díaz, Qingjie Li, Orianna Carter, Wan‐Mohaiza Dashwood, Christopher K. Mathews, David E. Williams, George S. Bailey & Roderick H. Dashwood. (2009) E2F4 and ribonucleotide reductase mediate S‐phase arrest in colon cancer cells treated with chlorophyllin. International Journal of Cancer 125:9, pages 2086-2094.
Crossref
Crossref
D.R. Richardson, D.S. Kalinowski, S. Lau, P.J. Jansson & D.B. Lovejoy. (2009) Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents. Biochimica et Biophysica Acta (BBA) - General Subjects 1790:7, pages 702-717.
Crossref
Crossref
Astrid Bernhaus, Monika Fritzer-Szekeres, Michael Grusch, Philipp Saiko, Georg Krupitza, Somepalli Venkateswarlu, Golakoti Trimurtulu, Walter Jaeger & Thomas Szekeres. (2009) Digalloylresveratrol, a new phenolic acid derivative induces apoptosis and cell cycle arrest in human HT-29 colon cancer cells. Cancer Letters 274:2, pages 299-304.
Crossref
Crossref
Sungwoo Park, Kyung-min Lee, Ji-hyun Ju, Jaeyoon Kim, Dong-Young Noh, Taehoon Lee & Incheol Shin. (2009)
Protein expression profiling of primary mammary epithelial cells derived from MMTV-
neu
mice revealed that HER2/NEU-driven changes in protein expression are functionally clustered
. IUBMB Life, pages NA-NA.
Crossref
Crossref
Loredana Cappellacci, Palmarisa Franchetti, Patrizia Vita, Riccardo Petrelli, Antonio Lavecchia, Hiremagalur N. Jayaram, Philipp Saiko, Geraldine Graser, Thomas Szekeres & Mario Grifantini. (2008)
Ribose-Modified Purine Nucleosides as Ribonucleotide Reductase Inhibitors. Synthesis, Antitumor Activity, and Molecular Modeling of
N
6
-Substituted 3′-
C
-Methyladenosine Derivatives
. Journal of Medicinal Chemistry 51:14, pages 4260-4269.
Crossref
Crossref
Francis J. Giles. (2007) A new era for ribonucleoside reductase inhibition. Leukemia Research 31:9, pages 1163-1164.
Crossref
Crossref
Ivana Gojo, Michael L. Tidwell, Jacqueline Greer, Naoko Takebe, Karen Seiter, Mary F. Pochron, Bonny Johnson, Mario Sznol & Judith E. Karp. (2007) Phase I and pharmacokinetic study of Triapine®, a potent ribonucleotide reductase inhibitor, in adults with advanced hematologic malignancies. Leukemia Research 31:9, pages 1165-1173.
Crossref
Crossref
Sibylle Madlener, Christoph Illmer, Zsuzsanna Horvath, Philipp Saiko, Annemarie Losert, Irene Herbacek, Michael Grusch, Howard L. Elford, Georg Krupitza, Astrid Bernhaus, Monika Fritzer-Szekeres & Thomas Szekeres. (2007) Gallic acid inhibits ribonucleotide reductase and cyclooxygenases in human HL-60 promyelocytic leukemia cells. Cancer Letters 245:1-2, pages 156-162.
Crossref
Crossref
Farhad Ravandi & Francis Giles. 2007. Acute Myelogenous Leukemia. Acute Myelogenous Leukemia
3
23
.
Paul A. Fowler, Jenny Tattum, Siladitya Bhattacharya, Thomas Klonisch, Sabine Hombach‐Klonisch, Rafet Gazvani, Richard G. Lea, Iain Miller, William G. Simpson & Phillip Cash. (2007) An investigation of the effects of endometriosis on the proteome of human eutopic endometrium: A heterogeneous tissue with a complex disease. PROTEOMICS 7:1, pages 130-142.
Crossref
Crossref
Karen W.L. Yee, Jorge Cortes, Alessandra Ferrajoli, Guillermo Garcia-Manero, Srdan Verstovsek, William Wierda, Deborah Thomas, Stefan Faderl, Ivan King, Susan M. O’Brien, Sima Jeha, Michael Andreeff, Ann Cahill, Mario Sznol & Francis J. Giles. (2006) Triapine and cytarabine is an active combination in patients with acute leukemia or myelodysplastic syndrome. Leukemia Research 30:7, pages 813-822.
Crossref
Crossref
Jimin Shao, Bingsen Zhou, Angel J. Di Bilio, Lijun Zhu, Tieli Wang, Christina Qi, Jennifer Shih & Yun Yen. (2006) A Ferrous-triapine complex mediates formation of reactive oxygen species that inactivate human ribonucleotide reductase. Molecular Cancer Therapeutics 5:3, pages 586-592.
Crossref
Crossref
Susana Pereira, Nuno M.F.S.A. Cerqueira, Pedro Alexandrino Fernandes & Maria João Ramos. (2005) Computational studies on class I ribonucleotide reductase: understanding the mechanisms of action and inhibition of a cornerstone enzyme for the treatment of cancer. European Biophysics Journal 35:2, pages 125-135.
Crossref
Crossref
Francis W Ruscetti, Salem Akel & Stephen H Bartelmez. (2005) Autocrine transforming growth factor-β regulation of hematopoiesis: many outcomes that depend on the context. Oncogene 24:37, pages 5751-5763.
Crossref
Crossref
Eduard Torrents, Andrzej Poplawski & Britt-Marie Sjöberg. (2005) Two Proteins Mediate Class II Ribonucleotide Reductase Activity in Pseudomonas aeruginosa. Journal of Biological Chemistry 280:17, pages 16571-16578.
Crossref
Crossref
Ruili Huang, Anders Wallqvist & David G. Covell. (2005) Anticancer metal compounds in NCI's tumor-screening database: putative mode of action. Biochemical Pharmacology 69:7, pages 1009-1039.
Crossref
Crossref
Jian He, Béatrice Roy, Christian Périgaud, Ossama B. Kashlan & Barry S. Cooperman. (2005) The enantioselectivities of the active and allosteric sites of mammalian ribonucleotide reductase. The FEBS Journal 272:5, pages 1236-1242.
Crossref
Crossref
Akira Matsuda & Takuma Sasaki. (2005) Antitumor activity of sugar‐modified cytosine nucleosides. Cancer Science 95:2, pages 105-111.
Crossref
Crossref
Francis J. Giles, Paula M. Fracasso, Hagop M. Kantarjian, Jorge E. Cortes, Randy A. Brown, Srdan Verstovsek, Yesid Alvarado, Deborah A. Thomas, Stefan Faderl, Guillermo Garcia-Manero, Lisa P. Wright, Tom Samson, Ann Cahill, Paula Lambert, William Plunkett, Mario Sznol, John F. DiPersio & Varsha Gandhi. (2003) Phase I and pharmacodynamic study of Triapine®, a novel ribonucleotide reductase inhibitor, in patients with advanced leukemia. Leukemia Research 27:12, pages 1077-1083.
Crossref
Crossref
Preethi Krishnan, Elizabeth A. Gullen, Wing Lam, Ginger E. Dutschman, Susan P. Grill & Yung-chi Cheng. (2003) Novel Role of 3-Phosphoglycerate Kinase, a Glycolytic Enzyme, in the Activation of L-Nucleoside Analogs, a New Class of Anticancer and Antiviral Agents. Journal of Biological Chemistry 278:38, pages 36726-36732.
Crossref
Crossref
Francis J. GilesHagop M. KantarjianJorge E. CortesGuillermo Garcia-ManeroSrdan VerstovsekStefan FaderlDeborah A. ThomasAlessandra FerrajoliSusan O’BrienJay K. WathenLian-Chun XiaoDonald A. BerryElihu H. Estey. (2003) Adaptive Randomized Study of Idarubicin and Cytarabine Versus Troxacitabine and Cytarabine Versus Troxacitabine and Idarubicin in Untreated Patients 50 Years or Older With Adverse Karyotype Acute Myeloid Leukemia. Journal of Clinical Oncology 21:9, pages 1722-1727.
Crossref
Crossref